These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19218376)

  • 1. A new type of coronary artery stent.
    Evans A; Davies RG
    Br J Anaesth; 2009 Mar; 102(3):435-6. PubMed ID: 19218376
    [No Abstract]   [Full Text] [Related]  

  • 2. Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force.
    Albaladejo P; Marret E; Piriou V; Samama CM;
    Br J Anaesth; 2006 Oct; 97(4):580-2. PubMed ID: 16956897
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery.
    Broad L; Lee T; Conroy M; Bolsin S; Orford N; Black A; Birdsey G
    Br J Anaesth; 2007 Jan; 98(1):19-22. PubMed ID: 17124186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery stents and non-cardiac surgery.
    Howard-Alpe GM; de Bono J; Hudsmith L; Orr WP; Foex P; Sear JW
    Br J Anaesth; 2007 May; 98(5):560-74. PubMed ID: 17456488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of patients with a drug-eluting coronary stent presenting for elective surgery.
    Bengeri S
    Br J Anaesth; 2007 Jun; 98(6):841; author reply 841-2. PubMed ID: 17519264
    [No Abstract]   [Full Text] [Related]  

  • 7. [Developments in percutaneous coronary intervention and coronary stents].
    Simsek C; Daemen J; Zijlstra F
    Ned Tijdschr Tandheelkd; 2014; 121(7-8):375-9. PubMed ID: 25174186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis.
    Joyal D; Freihage JH; Cohoon K; Tempelhof M; Leya F; Dieter RS; Steen L; Lewis B; Arab D
    J Invasive Cardiol; 2007 Jul; 19(7):291-4. PubMed ID: 17620672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perioperative management of patients with coronary artery stents: surveying the clinical stakeholders and arriving at a consensus regarding optimal care.
    Vetter TR; Boudreaux AM; Papapietro SE; Smith PW; Taylor BB; Porterfield JR
    Am J Surg; 2012 Oct; 204(4):453-461.e2. PubMed ID: 22621834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of drug-eluting stents.
    Riede FN; Pfisterer M; Jeger R
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1359-78. PubMed ID: 24138523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary stents and anaesthesia: it is time to have national data].
    Vichova Z; Albaladejo P; Marret E; Lehot JJ; Monier F; Marcotte G; Samama CM; Piriou V
    Ann Fr Anesth Reanim; 2007 Feb; 26(2):157-60. PubMed ID: 17188455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity-matched lesion-based comparison of midterm outcomes of TAXUS Express and TAXUS Liberté stents for de novo native coronary stenosis.
    Ishikawa T; Nakano Y; Hino S; Suzuki T; Murakami A; Tsutsumi J; Miyamoto T; Mutoh M
    J Cardiol; 2013 Nov; 62(5):289-95. PubMed ID: 23806548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy for elective coronary stenting: a moving target.
    Claeys MJ
    Semin Vasc Med; 2003 Nov; 3(4):415-8. PubMed ID: 15199448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary stents and non-cardiac surgery: current management strategies].
    Carrasco P; López R; Lema G
    Rev Med Chil; 2011 Jun; 139(6):787-93. PubMed ID: 22051761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stent thrombosis: an oversensationalized but unresolved problem?
    Latib A; Chieffo A; Colombo A
    Monaldi Arch Chest Dis; 2007 Mar; 68(1):1-5. PubMed ID: 17564287
    [No Abstract]   [Full Text] [Related]  

  • 18. French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.
    Angioi M; Barragan P; Cattan S; Collet F; Dupouy P; Durand P; Fajadet J; Finet G; Gerardin B; Gommeaux A; Karsenty B; Loubeyre C; Meyer P; Morice MC; Moulichon MÉ; Sayah S; Silvestri M; Tabone X; Unterseeh T; Wittenberg O; Lablanche JM
    Arch Cardiovasc Dis; 2012 Feb; 105(2):60-7. PubMed ID: 22424323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute thrombosis after primary percutaneous coronary intervention with bioresorbable vascular scaffold implantation.
    Tomaniak M; Kochman J; Kołtowski Ł; Pietrasik A; Rdzanek A
    Kardiol Pol; 2015; 73(4):300. PubMed ID: 25892264
    [No Abstract]   [Full Text] [Related]  

  • 20. Focused clinical review: periprocedural management of antiplatelet therapy in patients with coronary stents.
    Bell B; Layland J; Poon K; Spaulding C; Walters D
    Heart Lung Circ; 2011 Jul; 20(7):438-45. PubMed ID: 21493140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.